Asthma trials in Romania

In Romania 14 Also abroad 500

14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Where
Bucharest
Age
6 years to 11 years
People
200 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Where
Bucharest
Age
12 years to 17 years
People
188 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05776927
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Where
Bucharest
Age
5 years to 11 years
People
231 worldwide
Run by
AstraZeneca
See details and how to joinNCT06023589
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Where
Brasov, Bucharest, Cluj-Napoca, Craiova, Oradea, Timisoara, Timis
Age
12 years to 80 years
People
786 worldwide
Run by
Generate Biomedicines
See details and how to joinNCT07276724 · EU 2025-521950-41-00
Phase 1Taking people
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Where
Bucharest, Cluj-Napoca
Age
18 years to 65 years
People
84 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06433921 · EU 2024-511220-14-00
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Where
Brasov, Craiova, Timișoara
Age
18 years to 75 years
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07323654
Phase 2Not yet taking people in Romania
A Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
Where
Brasov, Craiova, Timisoara
Age
18 years and over
People
77 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2026-526241-98-00 · EU 2026-526241-98-00
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
Where
Brasov, Craiova, Timisoara
Age
18 years and over
People
121 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2025-523180-38-00 · EU 2025-523180-38-00
Phase 3Taking people
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
Where
Brasov, Bucharest, Craiova
Age
12 years and over
People
456 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07456033 · EU 2025-524463-20-00
Phase 3Taking people
A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
Where
Bucharest
Age
Up to 17 years
People
68 worldwide
Run by
Novartis Pharma AG
See details and how to join2022-502365-26-00 · EU 2022-502365-26-00
Phase 4Taking people
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Where
Bragadiru, Bucharest, Cluj-Napoca, Craiova, Iasi, Timisoara
Age
18 years and over
People
644 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07666490 · EU 2025-524289-56-00
Phase 2Taking people
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Where
Craiova
Age
18 years to 75 years
People
512 worldwide
Run by
Kinaset Therapeutics Inc
See details and how to joinNCT07532265 · EU 2023-509125-41-00
Phase 2Taking people
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
Where
Bacau, Bragadiru, Brasov, Bucaresti, Bucharest, Cluj-Napoca, Craiova, Deva, Oradea, Timisoara, Timișoara
Age
18 years to 75 years
People
780 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00
No phaseNot yet taking people in Romania
Design, Development and Evaluation of a Digital Health Assistant for Paediatric Asthma
Where
Brasov, Bucharest, Suceava, Timișoara
Age
10 years to 19 years
People
42
Run by
University Children's Hospital Basel
See details and how to joinNCT07472283